AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33068617 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher Ocular Surface Disease Index (OSDI) symptom scores
Number of subjects: 535
Study 33068617 — intervention group
Group type: EXPERIMENTAL
Intervention: Longitudinal increases (worsening) in OSDI scores
Number of subjects: 535
Study 33068617 — intervention group
Group type: EXPERIMENTAL
Intervention: Worse corneal staining and tear break‐up time
Number of subjects: 535
Study 35748760 — intervention group
Group type: EXPERIMENTAL
Intervention: The Daily Mile (TDM) - a daily one mile outdoor run/walk performed at a self‐selected pace during school hours
Number of subjects: 550
Study 35748760 — intervention group
Group type: EXPERIMENTAL
Intervention: The Daily Mile (TDM)
Number of subjects: 550
Study 34727088 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help intervention (n = 123)
Number of subjects: 264
Study 34727088 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (n = 141)
Number of subjects: 264
Study 32584005 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct stenting (Group I)
Number of subjects: 100
Study 32584005 — intervention group
Group type: COMPARATOR
Intervention: Stenting after balloon pre-dilatation (Group II)
Number of subjects: 100
Study 35546449 — intervention group
Group type: EXPERIMENTAL
Intervention: HDV-insulin lispro with a 10% decrease in BaI dose
Number of subjects: 52
Study 35546449 — intervention group
Group type: EXPERIMENTAL
Intervention: HDV-insulin lispro with a 40% decrease in BaI dose
Number of subjects: 52
Study 34343678 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee Image Digital Analysis (KIDA)
Number of subjects: 103
Study 35903320 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 196
Study 35903320 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture (SA)
Number of subjects: 196
Study 33048394 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening attendance (at least twice)
Number of subjects: 31867
Study 33048394 — intervention group
Group type: COMPARATOR
Intervention: Single screening
Number of subjects: 31867
Study 33048394 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated screening
Number of subjects: 31867
Study 33048394 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of screens attended
Number of subjects: 31867
Study 33048394 — intervention group
Group type: COMPARATOR
Intervention: Control arm (non-attenders)
Number of subjects: 31867
Study 33048394 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate-risk and high-risk cases
Number of subjects: 31867
Study 33461775 — intervention group
Group type: EXPERIMENTAL
Intervention: Mathematical formula defining horizontal cervical tooth geometry for prefabricated healing abutments.
Number of subjects: 54
Study 33461775 — intervention group
Group type: EXPERIMENTAL
Intervention: Cone beam computed tomography (CBCT) measurements of tooth geometry.
Number of subjects: 54
Study 33139136 — intervention group
Group type: EXPERIMENTAL
Intervention: aQIV
Number of subjects: 2208
Study 33139136 — intervention group
Group type: COMPARATOR
Intervention: QIV
Number of subjects: 2208
Study 34715000 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting injectable antipsychotics (LAI)
Number of subjects: 60
Study 34715000 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral atypical antipsychotics (OAA)
Number of subjects: 60
Study 34715000 — intervention group
Group type: COMPARATOR
Intervention: Both LAI and OAA
Number of subjects: 60
Study 34183032 — intervention group
Group type: EXPERIMENTAL
Intervention: Best RMSSD (Root Mean Square of the Successive Differences)
Number of subjects: 252
Study 34183032 — intervention group
Group type: EXPERIMENTAL
Intervention: Good Stress Balance (SB)
Number of subjects: 252
Study 34183032 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup analysis among participants working regular daytime hours (n = 216)
Number of subjects: 252
Study 34651528 — intervention group
Group type: EXPERIMENTAL
Intervention: WeChat-assisted health education and preoperative care
Number of subjects: 0
Study 34651528 — intervention group
Group type: COMPARATOR
Intervention: Leaflet group (control)
Number of subjects: 0
Study 34015555 — intervention group
Group type: EXPERIMENTAL
Intervention: OLZ/SAM
Number of subjects: 265
Study 32333524 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxic ambulation (HAMB)
Number of subjects: 12
Study 32333524 — intervention group
Group type: COMPARATOR
Intervention: Normoxic bed rest (NBR)
Number of subjects: 12
Study 32333524 — intervention group
Group type: COMPARATOR
Intervention: Hypoxic bed rest (HBR)
Number of subjects: 12
Study 32333524 — intervention group
Group type: COMPARATOR
Intervention: Normoxic bed rest (NBR) and Hypoxic bed rest (HBR)
Number of subjects: 12
Study 36207675 — intervention group
Group type: EXPERIMENTAL
Intervention: Partially hydrolyzed protein formula with added Lacticaseibacillus rhamnosus GG (PHF-LGG)
Number of subjects: 71
Study 36207675 — intervention group
Group type: COMPARATOR
Intervention: Marketed partially hydrolyzed cow's milk-based infant formula (PHF)
Number of subjects: 71
Study 36207675 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulas (PHF and PHF-LGG)
Number of subjects: 71
Study 33786649 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (AZI) 500 mg/day for 3 days
Number of subjects: 40
Study 33786649 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 33786649 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (AZI + SRP and placebo + SRP)
Number of subjects: 40
Study 32891794 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-printed model and associated intervention including didactic instruction, multimedia content, and FNP practice
Number of subjects: 24
Study 34330456 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 supplementation (2000 mg/d)
Number of subjects: 60
Study 34330456 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 34118498 — intervention group
Group type: EXPERIMENTAL
Intervention: IVY intervention (vaccine education and quality improvement program)
Number of subjects: 4041
Study 34106794 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixekizumab (IXE)
Number of subjects: 0
Study 34106794 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32167864 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumor deposits positive patients
Number of subjects: 1942
Study 32167864 — intervention group
Group type: COMPARATOR
Intervention: Tumor deposits negative patients
Number of subjects: 1942
Study 32167864 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariable analysis including TDs
Number of subjects: 1942
Study 36145164 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet (LF)
Number of subjects: 0
Study 36145164 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (Med)
Number of subjects: 0
Study 36145164 — intervention group
Group type: EXPERIMENTAL
Intervention: Both diets (LF and Med)
Number of subjects: 0
Study 34407695 — intervention group
Group type: EXPERIMENTAL
Intervention: Sachet water (46% consumption); bottled water (100%, n=2); chlorine-based disinfectants for water treatment
Number of subjects: 100
Study 34407695 — intervention group
Group type: EXPERIMENTAL
Intervention: POC water samples
Number of subjects: 100
Study 32894248 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological interventions (specific interventions not detailed)
Number of subjects: 9
Study 35246219 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized telephone-based weight loss intervention plus health education
Number of subjects: 220
Study 35246219 — intervention group
Group type: COMPARATOR
Intervention: Health education alone
Number of subjects: 220
Study 33522950 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 75
Study 33522950 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 75
Study 33522950 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 75
Study 33559648 — intervention group
Group type: EXPERIMENTAL
Intervention: Air pollution exposure (measured by particulate matter PM2.5 and PM10)
Number of subjects: 276
Study 33559648 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin prick testing and measurement of volatile organic compounds in exhaled breath
Number of subjects: 276
Study 32147075 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcuminoids (500 mg plus 5 mg piperine per day for 8 weeks)
Number of subjects: 55
Study 36201761 — intervention group
Group type: EXPERIMENTAL
Intervention: HRV biofeedback (HRV‐BF), 4 sessions
Number of subjects: 50
Study 36201761 — intervention group
Group type: COMPARATOR
Intervention: Autogenic training (AT), 4 sessions
Number of subjects: 50
Study 34235821 — intervention group
Group type: EXPERIMENTAL
Intervention: Valvular heart disease trials
Number of subjects: 9071
Study 34235821 — intervention group
Group type: COMPARATOR
Intervention: Coronary artery disease trials
Number of subjects: 9071
Study 34235821 — intervention group
Group type: COMPARATOR
Intervention: Stroke trials
Number of subjects: 9071
Study 34235821 — intervention group
Group type: COMPARATOR
Intervention: Atrial fibrillation trials
Number of subjects: 9071
Study 34235821 — intervention group
Group type: COMPARATOR
Intervention: Surgical procedures
Number of subjects: 9071
Study 34235821 — intervention group
Group type: COMPARATOR
Intervention: Drugs
Number of subjects: 9071
Study 34235821 — intervention group
Group type: COMPARATOR
Intervention: Secondary prevention
Number of subjects: 9071
Study 34235821 — intervention group
Group type: COMPARATOR
Intervention: Primary prevention
Number of subjects: 9071
Study 34235821 — intervention group
Group type: COMPARATOR
Intervention: Tertiary prevention
Number of subjects: 9071
Study 34235821 — intervention group
Group type: COMPARATOR
Intervention: Age groups ≤50 years old
Number of subjects: 9071
Study 34235821 — intervention group
Group type: COMPARATOR
Intervention: Age groups 56-60 years old
Number of subjects: 9071
Study 32436902 — intervention group
Group type: EXPERIMENTAL
Intervention: omega-3 fatty acids 500 mg (EPA/DHA 180/120 mg), BD daily for 1 month
Number of subjects: 90
Study 32436902 — intervention group
Group type: COMPARATOR
Intervention: scaling and root planing only
Number of subjects: 90
Study 35524839 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 48389
Study 35524839 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 48389
Study 35524839 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 48389
Study 35524839 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 48389
Study 35524839 — intervention group
Group type: EXPERIMENTAL
Intervention: NOACs (nonvitamin K antagonist oral anticoagulants)
Number of subjects: 48389
Study 33258688 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote risk-based monitoring
Number of subjects: 11
Study 33258688 — intervention group
Group type: COMPARATOR
Intervention: On-site monitoring with 100% source data verification
Number of subjects: 11
Study 33258688 — intervention group
Group type: COMPARATOR
Intervention: Data review by data managers
Number of subjects: 11
Study 35281417 — intervention group
Group type: EXPERIMENTAL
Intervention: SILS+1
Number of subjects: 117
Study 35281417 — intervention group
Group type: COMPARATOR
Intervention: CLS
Number of subjects: 117
Study 35447066 — intervention group
Group type: EXPERIMENTAL
Intervention: Tick Control System (TCS)
Number of subjects: 24
Study 35447066 — intervention group
Group type: EXPERIMENTAL
Intervention: Met52 fungal spray
Number of subjects: 24
Study 35447066 — intervention group
Group type: EXPERIMENTAL
Intervention: TCS and Met52 used together
Number of subjects: 24
Study 35447066 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 24
Study 32366155 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorafenib
Number of subjects: 74
Study 32366155 — intervention group
Group type: EXPERIMENTAL
Intervention: M2
Number of subjects: 74
Study 32366155 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorafenib or M2
Number of subjects: 74
Study 36253611 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-tau monoclonal antibody gosuranemab
Number of subjects: 0
Study 36253611 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34454786 — intervention group
Group type: COMPARATOR
Intervention: Ro‐VLP vaccine (21 μg) in adults
Number of subjects: 70
Study 34454786 — intervention group
Group type: COMPARATOR
Intervention: Ro‐VLP vaccine (7 μg or 21 μg) in toddlers
Number of subjects: 70
Study 34454786 — intervention group
Group type: COMPARATOR
Intervention: Ro‐VLP vaccine (2.5 μg, 7 μg or 21 μg) in infants
Number of subjects: 70
Study 34454786 — intervention group
Group type: COMPARATOR
Intervention: Oral Rotarix (2 doses) in infants
Number of subjects: 70
Study 35908553 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured leadership and management training, facilitating subregional collaboration, and routine data feedback to mid-level managers.
Number of subjects: 82
Study 35908553 — intervention group
Group type: COMPARATOR
Intervention: Standard practice (control group).
Number of subjects: 82
Study 35908553 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured leadership and management training, facilitating subregional collaboration, and routine data feedback to mid-level managers (excluding Q3-2019).
Number of subjects: 82
Study 35908553 — intervention group
Group type: COMPARATOR
Intervention: Standard practice (control group, excluding Q3-2019).
Number of subjects: 82
Study 33528749 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 308
Study 33528749 — intervention group
Group type: EXPERIMENTAL
Intervention: Charlson comorbidity index (CCI 5)
Number of subjects: 308
Study 33528749 — intervention group
Group type: EXPERIMENTAL
Intervention: Venous and/or perineural invasion
Number of subjects: 308
Study 33528749 — intervention group
Group type: EXPERIMENTAL
Intervention: Perineural invasion
Number of subjects: 308
Study 33528749 — intervention group
Group type: EXPERIMENTAL
Intervention: Incomplete resection
Number of subjects: 308
Study 33528749 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative mortality rate
Number of subjects: 308
Study 32270474 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mL ropivacaine 0.2% bilaterally and an elastomeric pump containing 0.2% ropivacaine
Number of subjects: 24
Study 32270474 — intervention group
Group type: COMPARATOR
Intervention: 30 mL saline bilaterally and an elastomeric pump containing saline
Number of subjects: 24
Study 32744473 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender training intervention
Number of subjects: 0
Study 33008432 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor Imagery practice combined with routine physical therapy (MIp)
Number of subjects: 26
Study 33008432 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving physical therapy alone (CON)
Number of subjects: 26
Study 35820247 — intervention group
Group type: EXPERIMENTAL
Intervention: Request
Number of subjects: 97
Study 35820247 — intervention group
Group type: EXPERIMENTAL
Intervention: Offer
Number of subjects: 97
Study 35820247 — intervention group
Group type: COMPARATOR
Intervention: Telling
Number of subjects: 97
Study 33356403 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound renal denervation (RDN)
Number of subjects: 122
Study 33356403 — intervention group
Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 122
Study 34404275 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholic beverage
Number of subjects: 438
Study 34404275 — intervention group
Group type: COMPARATOR
Intervention: Nonalcoholic beverage (no-alcohol control or placebo)
Number of subjects: 438
Study 34512759 — intervention group
Group type: EXPERIMENTAL
Intervention: Pomegranate peel extract mouthwash
Number of subjects: 60
Study 34512759 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine mouthwash
Number of subjects: 60
Study 35351144 — intervention group
Group type: EXPERIMENTAL
Intervention: Inulin (16 g/day) with dietary advice for 3 months
Number of subjects: 106
Study 35351144 — intervention group
Group type: EXPERIMENTAL
Intervention: Inulin with increased physical activity
Number of subjects: 106
Study 35351144 — intervention group
Group type: COMPARATOR
Intervention: Placebo (maltodextrin) with dietary advice for 3 months
Number of subjects: 106
Study 33924761 — intervention group
Group type: EXPERIMENTAL
Intervention: W. cibaria CMU tablets administered once daily for 8 weeks before bedtime
Number of subjects: 68
Study 33924761 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered once daily for 8 weeks before bedtime
Number of subjects: 68
Study 34390436 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer use (goal of 10,000 steps/day)
Number of subjects: 38
Study 34390436 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer use
Number of subjects: 38
Study 34390436 — intervention group
Group type: COMPARATOR
Intervention: Control group (no pedometer)
Number of subjects: 38
Study 35297360 — intervention group
Group type: EXPERIMENTAL
Intervention: Children of mothers who gained the most gestational weight
Number of subjects: 1112
Study 35297360 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with the highest birth weight, body length and head circumference
Number of subjects: 1112
Study 35297360 — intervention group
Group type: EXPERIMENTAL
Intervention: Children of relatively younger mothers
Number of subjects: 1112
Study 35297360 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents of preschoolers in the high adiposity category
Number of subjects: 1112
Study 35297360 — intervention group
Group type: EXPERIMENTAL
Intervention: Boys with the highest adiposity
Number of subjects: 1112
Study 34217356 — intervention group
Group type: EXPERIMENTAL
Intervention: New amino acid-based formula (AAF)
Number of subjects: 29
Study 34217356 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 32665367 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral immunotherapy (Palforzia)
Number of subjects: 0
Study 32665367 — intervention group
Group type: EXPERIMENTAL
Intervention: Palforzia
Number of subjects: 0
Study 34119410 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping with voice therapy
Number of subjects: 30
Study 32902700 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 119
Study 32902700 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 119
Study 32868182 — intervention group
Group type: EXPERIMENTAL
Intervention: Early on-demand percutaneous catheter drainage (PCD)
Number of subjects: 120
Study 32868182 — intervention group
Group type: COMPARATOR
Intervention: Standard management (deferred PCD until walled off)
Number of subjects: 120
Study 35203045 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K2 (360 µg/d)
Number of subjects: 41
Study 35203045 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 33894665 — intervention group
Group type: EXPERIMENTAL
Intervention: ACTH
Number of subjects: 95
Study 33894665 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone
Number of subjects: 95
Study 32590959 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based pain education and exercise program
Number of subjects: 160
Study 32590959 — intervention group
Group type: COMPARATOR
Intervention: Online self-management booklet
Number of subjects: 160
Study 34704817 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitoring (RT-CGM), n=100
Number of subjects: 147
Study 34704817 — intervention group
Group type: COMPARATOR
Intervention: Blood glucose monitoring (BGM), n=47
Number of subjects: 147
Study 34108169 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (10 telephone-based sessions over 16 weeks)
Number of subjects: 270
Study 34108169 — intervention group
Group type: COMPARATOR
Intervention: Dietary advice (equivalent dose of telephone-based sessions)
Number of subjects: 270
Study 34108169 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing
Number of subjects: 270
Study 34108169 — intervention group
Group type: COMPARATOR
Intervention: Dietary advice
Number of subjects: 270
Study 32544119 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural topical skin ointment (aloe vera, honey, and peppermint)
Number of subjects: 28
Study 32544119 — intervention group
Group type: COMPARATOR
Intervention: Petroleum jelly
Number of subjects: 28
Study 36228401 — intervention group
Group type: EXPERIMENTAL
Intervention: Nesfatin-1
Number of subjects: 110
Study 36228401 — intervention group
Group type: EXPERIMENTAL
Intervention: Irisin
Number of subjects: 110
Study 36228401 — intervention group
Group type: EXPERIMENTAL
Intervention: Adropin
Number of subjects: 110
Study 36228401 — intervention group
Group type: EXPERIMENTAL
Intervention: Preptin
Number of subjects: 110
Study 36228401 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 110
Study 32994552 — intervention group
Group type: EXPERIMENTAL
Intervention: Migalastat treatment
Number of subjects: 97
Study 34921717 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung ultrasound (LUS) combined with procalcitonin (PCT)
Number of subjects: 194
Study 34921717 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest X-Ray (CXR) combined with procalcitonin (PCT)
Number of subjects: 194
Study 34921717 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung ultrasound (LUS)
Number of subjects: 194
Study 34921717 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest X-Ray (CXR)
Number of subjects: 194
Study 32881994 — intervention group
Group type: EXPERIMENTAL
Intervention: C-Reactive Protein (CRP)
Number of subjects: 1678
Study 32881994 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin (PCT)
Number of subjects: 1678
Study 32881994 — intervention group
Group type: EXPERIMENTAL
Intervention: White Blood Count (WBC)
Number of subjects: 1678
Study 36327435 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholate berberine salt
Number of subjects: 0
Study 36327435 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35915734 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided technology
Number of subjects: 94
Study 35915734 — intervention group
Group type: COMPARATOR
Intervention: X-ray examination
Number of subjects: 94
Study 33742478 — intervention group
Group type: EXPERIMENTAL
Intervention: Lay health workers (LHWs) providing injectable contraception services
Number of subjects: 460